- Same active ingredient: tirzepatide, made by Lilly.
- Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight management and sleep apnea.
- Same missed dose rule (within 4 days) and same storage rules by device.
- Same injection sites: stomach or thigh, or the back of the upper arm if someone else injects.
- Different savings programs. The Medicare GLP-1 Bridge covers the Zepbound KwikPen, not Mounjaro.
At a glance
| Mounjaro | Zepbound | |
|---|---|---|
| Active ingredient | Tirzepatide | Tirzepatide |
| Maker | Eli Lilly | Eli Lilly |
| Approved for | Type 2 diabetes (adults and children 10 and older); cardiovascular risk reduction in adults with type 2 diabetes at high risk | Weight management in adults; moderate to severe obstructive sleep apnea in adults with obesity |
| How often | Once a week | Once a week |
| Missed dose | Within 4 days (96 hours), otherwise skip | Within 4 days (96 hours), otherwise skip |
| Devices | Single-dose pen, KwikPen, single-dose and multi-dose vials | Single-dose pen, KwikPen, single-dose vial |
From each prescribing information and Lilly's Instructions for Use.[2, 1, 3, 4, 5]
What each is approved for
Mounjaro
Mounjaro is approved, with diet and exercise, to improve blood sugar in adults and children 10 years and older with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes who are at high risk.[2]
Zepbound
Zepbound is approved for weight management in adults with obesity, or adults with overweight who also have at least one weight-related condition.[1] It is also approved for moderate to severe obstructive sleep apnea in adults with obesity.[1]
So although the medicine inside is the same, the two brands are approved for different groups of people. That is why a prescriber, and an insurance plan, will usually treat them as two different products.
Devices and strengths
- Zepbound comes as a single-dose pen, a single-dose vial and a multi-dose KwikPen.[3, 4, 5] Its strengths are 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.[7, 8]
- Mounjaro comes as a single-dose pen, a single-patient-use KwikPen, and single-dose and multi-dose vials.[2]
The pens look alike but are not interchangeable. Follow the Instructions for Use for the exact brand and device in your hand. Our step-by-step guides cover each one: Mounjaro andZepbound.
What is the same
- Schedule: once a week, at any time of day, with or without meals.[1, 2]
- Missed doses: take it as soon as possible within 4 days (96 hours). After that, skip it and take the next dose on your usual day. To change your injection day, leave at least 3 days (72 hours) between doses.[1, 2] More in our missed dose guide.
- Injection sites: your stomach (abdomen) or thigh, or the back of your upper arm if someone else gives the injection.[3, 6] The free logbooktracks your rotation for either brand.
- Storage: single-dose pens and vials can stay at room temperature up to 86°F for a total of 21 days. Never freeze them.[3, 4, 6, 2] KwikPens follow a 30-day rule. See how to store Zepbound and Mounjaro.
Cost and coverage
Because the brands are approved for different conditions, they have separate savings programs and are often covered under different insurance rules. Current self-pay prices for both, by dose, are on ourGLP-1 price checker.
- Zepbound: Lilly offers a savings card for people with commercial insurance, and self-pay prices for the KwikPen and vials.[9] Details are in ourZepbound savings guide.
- Medicare: the Medicare GLP-1 Bridge covers the Zepbound KwikPen for $50 a month for eligible people. Its eligibility rules exclude people with type 2 diabetes, so it does not apply to someone prescribed Mounjaro for diabetes.[10]
- Mounjaro: ask your insurer or pharmacist how your plan covers it. This guide does not yet list Mounjaro savings programs.
Which one will I get?
That is your prescriber's decision. It usually starts with which label fits your diagnosis: type 2 diabetes points to Mounjaro, and weight management or sleep apnea without diabetes points to Zepbound. Your insurance plan's rules matter too. Do not change, combine or switch GLP-1 medicines without talking to your prescriber.
Common questions
Are Mounjaro and Zepbound the same drug?
They contain the same active ingredient, tirzepatide, and both are made by Eli Lilly. They are separate brands with separate FDA labels: Mounjaro is approved for type 2 diabetes, and Zepbound for weight management and obstructive sleep apnea.
What is the difference between Mounjaro and Zepbound?
The main difference is what each is approved for. Mounjaro is approved to improve blood sugar in type 2 diabetes and to reduce cardiovascular risk in adults with type 2 diabetes at high risk. Zepbound is approved for weight management in adults with obesity, or overweight with a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity.
Do Mounjaro and Zepbound have the same missed dose rule?
Yes. Both labels say to take a missed dose as soon as possible within 4 days (96 hours). If more than 4 days have passed, skip it and take the next dose on your usual day.
Are the storage rules the same?
Yes, format for format. Single-dose pens and vials can be kept at room temperature up to 86°F for a total of 21 days. KwikPens follow a 30-day rule. Never freeze either medicine.
Can I switch from Mounjaro to Zepbound?
That is a decision for your prescriber. Each brand is approved for different conditions, and insurance plans often cover them under different rules. Do not change or combine GLP-1 medicines without talking to your prescriber.
Sources
- Eli Lilly and Company. Zepbound (tirzepatide) Prescribing Information. Revised 08/2026. Last checked 2026-10-01.
- Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. Revised 08/2026. Last checked 2026-10-01.
- Eli Lilly and Company. Zepbound single-dose pen Instructions for Use. Revised April 2026. Last checked 2026-10-01.
- Eli Lilly and Company. Zepbound single-dose vial Instructions for Use. Revised April 2026. Last checked 2026-10-01.
- Eli Lilly and Company. Zepbound KwikPen Instructions for Use. Revised January 2026. Last checked 2026-10-01.
- Eli Lilly and Company. Mounjaro single-dose pen Instructions for Use. Revised April 2026. Last checked 2026-10-01.
- Eli Lilly and Company (press release). Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen. Revised February 23, 2026. Last checked 2026-10-01.
- Eli Lilly and Company. How to use Zepbound. Revised n/a (web page). Last checked 2026-10-01.
- Eli Lilly and Company. Zepbound savings and coverage options. Revised n/a (web page, programs through 12/31/2026). Last checked 2026-11-04.
- Centers for Medicare and Medicaid Services. Medicare GLP-1 Bridge: GLP-1 Drugs for $50 a Month (fact sheet). Revised n/a (program began July 1, 2026). Last checked 2026-10-01.